Comorbidities, Dosing Issues, Polypharmacy, and Adverse Effects in Prostate Cancer |
0.50 |
04/26/2023 - 12:00am to 03/31/2024 - 12:00am |
Management of Newly Diagnosed Multiple Myeloma Based on Risk Stratification |
0.50 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Caring for Patients with Advanced Cancer - Part 1 |
0.50 |
08/04/2022 - 12:00am to 08/04/2024 - 12:00am |
Incorporating Immunotherapeutic Strategies in the Management of Relapsed/Refractory Multiple Myeloma |
0.50 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Caring for Patients with Advanced Cancer - Part 2: Preparing for End of Life |
0.50 |
08/04/2022 - 12:00am to 08/04/2024 - 12:00am |
Managing Multiple Medications – Polypharmacy |
0.50 |
08/04/2022 - 12:00am to 08/04/2024 - 12:00am |
Advances in the Management of Classical Hodgkin Lymphoma |
0.50 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Supporting Cancer Patients with Substance Use Disorder |
0.50 |
08/04/2022 - 12:00am to 08/04/2024 - 12:00am |
Perioperative Management of Anticoagulation and Antithrombotic Therapy |
0.50 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Supporting Cancer Patients with Post-traumatic Stress Disorder (PTSD) |
0.50 |
08/04/2022 - 12:00am to 08/04/2024 - 12:00am |
Relapsed/Refractory CLL/SLL: Overcoming Resistance to Covalent BTKi and/or BCL2 Inhibitors |
0.50 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Cardiovascular Health After Breast Cancer Treatment |
0.50 |
03/15/2024 - 12:00am to 03/15/2025 - 12:00am |
Management of Graft-Versus-Host Disease in Hematopoietic Cell Transplant Recipients |
0.50 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Integrative Medicine and the Cancer Patient |
0.50 |
08/04/2022 - 12:00am to 08/04/2024 - 12:00am |
Management of Lower-Risk Myelodysplastic Syndromes |
0.50 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |